antipsychotic medication,aripiprazole,atypical antipsychotic medications,atypical antipsychotics,fda approval,food and drug administration,food and drug administration fda,iloperidone,medical literature,meta analysis,new insights,observational studies,obsessive compulsive disorder,paliperidone,personality disorders,...
Additionally, typical antipsychotics have been used for a long time and have been well-studied. They are generally less expensive than atypical antipsychotics, making them a more accessible option for some. Despite their potential side effects, typical antipsychotics remain a valuable tool in managing ...
Discusses research being done on the association between the use of atypical antipsychotics and medication switching. Reference to a study by G. W. K. Hugenholtz et al, published in the January 2004 issue of the journal "European Neuropsychopharmacology"; Increase in the risk of switching in ...
Davis JMChen NGlick ID A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003;60553- 564ArticlePubMedGoogle ScholarCrossref 49. Tuunainen AWahlbeck KGilbody S Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized ...
In the real world, most patients taking atypical antipsychotics take other drugs (psychiatric or nonpsychiatric). Moreover, polypharmacy is often the norm in the consultation/liaison, med-psych setting. The use of multiple medications increases the possibility that clinically relevant drug-drug ...
Patients should be educated about the adverse effects of abruptly discontinuing the use of atypical antipsychotics. Instruct patients that if they are having difficulty tolerating their medication or if for any reason, they are thinking they will stop taking their antipsychotic, they should not disconti...
abilify,antidepressant,antipsychotic medication,antipsychotic medications,atypical antipsychotic drugs,atypical antipsychotics,calendar quarter,diabetes and heart disease,drug compendium,fda approval,followup studies,heart disease,ims health,information company,md phd,new generation,prescriptions,psychiatric medications,...
Atypical antipsychotics associated with less medication switchingInpharma Weekly -doi:10.2165/00128413-200414210-00013NonePharmacoEconomics and Outcomes News
Discusses research being done on the association between the use of atypical antipsychotics and medication switching. Reference to a study by G. W. K. Hugenholtz et al, published in the January 2004 issue of the journal "European Neuropsychopharmacology"; Increase in the risk of switching in ...
Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitustype 2 diabetes mellitusatypical antipsy-choticsantidepressantsstimulantsMedicaidObjective: More than half of youth treated with atypical antipsychotic (AAP) medications are also ...